Published online before print May 23, 2008

This Article Full Text (Rapid PDF) All Versions of this Article: ajpath.2008.070583v1 173/1/30    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Giannopoulou, M. Articles by Liu, Y. Search for Related Content PubMed PubMed Citation Articles by Giannopoulou, M. Articles by Liu, Y.

Copyright © 2008 American Society for Investigative Pathology
American Journal of Pathology, doi:10.2353/ajpath.2008.070583

Accepted for publication March 31, 2008.

Article

Hepatocyte Growth Factor Exerts Its Anti-Inflammatory Action by Disrupting Nuclear Factor-B Signaling

From the Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

^@ To whom correspondence should be addressed. E-mail: liuy{at}upmc.edu.

	Abstract

Renal inflammation, characterized by the influx of inflammatory cells, is believed to play a critical role in the initiation and progression of a wide range of chronic kidney diseases. Here, we show that hepatocyte growth factor (HGF) inhibited renal inflammation and proinflammatory chemokine expression by disrupting nuclear factor (NF)-B signaling. In vivo, HGF gene delivery inhibited interstitial infiltration of inflammatory T cells and macrophages, and suppressed expression of both RANTES (regulated on activation, normal T cell expressed and secreted) and monocyte chemoattractant protein-1 in a mouse model of obstructive nephropathy. In vitro, HGF abolished RANTES induction in human kidney epithelial cells, which was dependent on NF-B signaling. HGF did not significantly affect the phosphorylation or degradation of IB; it also did not influence the phosphorylation or nuclear translocation of p65 NF-B. However, HGF prevented p65 NF-B binding to its cognate cis-acting element in the RANTES promoter. HGF action was dependent on the activation of the phosphoinositide 3-kinase/Akt pathway, which led to the phosphorylation and inactivation of glycogen synthase kinase (GSK)-3. Suppression of GSK-3 activity mimicked HGF and abolished RANTES expression, whereas ectopic expression of GSK-3 restored RANTES induction. HGF also induced renal GSK-3 phosphorylation and inactivation after obstructive injury in vivo. These observations suggest that HGF is a potent anti-inflammatory cytokine that inhibits renal inflammation by disrupting NF-B signaling and may be a promising therapeutic agent for progressive renal diseases.

This article has been cited by other articles:

				X. Tan, X. Wen, and Y. Liu Paricalcitol Inhibits Renal Inflammation by Promoting Vitamin D Receptor-Mediated Sequestration of NF-{kappa}B Signaling J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1741 - 1752. [Abstract] [Full Text] [PDF]